language_icon
EN
HI

Jenburkt Pharmaceuticals Share price

JENBURPH

1177

11.05 (0.95%)
Last updated on 13 May, 2026 | 15:30 IST
Today's High

1194.00

Today's Low

1152.15

52 Week Low

944.00

52 Week High

1410.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Jenburkt Pharmaceuticals Chart

Jenburkt Pharmaceuticals Share Key Metrics

Volume
2822.00
Market Cap
514.57 CR
LTQ@LTP
15@1177.00
ATP
1186.07
Var Margin
19.3 %
Circuit Range
932.8-1399.1
Delivery %
62.45 %
Value
33.47 L
ASM/GSM
No
Market Lot
1

Summary

13 May, 2026 | 15:30 को, Jenburkt Pharmaceuticals का शेयर प्राइस आज ₹1177 पर है, जो दिन के लिए 11.05% की 0.95 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1152.15 और ₹1194.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹944.00 से ₹1410.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Jenburkt Pharmaceuticals ने 2822 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹4413300 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹118607 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 15,117700 रही। यह स्टॉक ₹932.8-1399.1 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹33.47 L है। दिन के लिए डिलीवरी परसेंटेज 62.45% रही। इसके अतिरिक्त, Jenburkt Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Jenburkt Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

67.07

Sector P/B

3.49

Sec. Div. Yield

0.57

Jenburkt Pharmaceuticals Resistance and Support

Pivot 1161.08

Resistance

First Resistance

1189.56

Second Resistance

1213.18

Third Resistance

1241.66

Support

First Support

1137.46

Second Support

1108.98

Third Support

1085.36

Jenburkt Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2025-26
  • 2024-25
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

46.69%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.12%

Retail

53.2%

Others

-0.01%

Total Promoters
MAR '24
47.23%
JUN '24
46.71%
SEP '24
46.71%
DEC '24
46.69%

Jenburkt Pharmaceuticals Corporate Actions

DateAgenda
2026-05-05Audited Results
2026-02-03Quarterly Results

Jenburkt Pharmaceuticals News

Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date

Jenburkt Pharmaceuticals fixed August 28, 2026, as record date for dividend payment for FY26. This date also determines e-voting eligibility for the 41st Annual General Meeting scheduled on September 04, 2026.
May 06 2026 14:05:00

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management

Jenburkt Pharmaceuticals re-appointed Shri Dilip H. Bhuta as Whole Time Director and CFO for a five-year term, effective April 1, 2027 to March 31, 2032. This re-appointment provides leadership stability and continuity.
May 05 2026 19:05:00

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th May, 2026.

Jenburkt Pharmaceuticals board approved the audited financial results for FY26, reporting ₹168.74 crore in revenue and ₹34.74 crore in net profit. The board also declared a final dividend of ₹20.70 per equity share and re-appointed Shri Dilip H. Bhuta as Whole Time Director and CFO for five years.
May 05 2026 19:05:00

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Taking On Record The Audited Financial Results For The Quarter And Financial Year Ended On 31St March, 2026 And To Consider Recommendation Of Dividend, If Any.

Jenburkt Pharmaceuticals' Board of Directors will convene on May 05, 2026. The agenda includes approval of audited financial results for Q4 FY26 and the full financial year, along with considering a dividend recommendation.
Apr 28 2026 16:04:00
Read More

About Jenburkt Pharmaceuticals AboutThe

NSE : 0  
BSE : 524731  
ISIN : INE354A01013  

The Company was originally incorporated as a PrivateLimited Company on 10th June 1985 in the state ofMaharastra Bombay and subsequently converted into a PublicLimited Company on 4th January 1994 and obtainedcertificate of change of name from the Registrar ofCompanies on 31 st January 1994. The Company has been promoted by ''BHUTA'' Family. The Bhutafamily is having interest in various business activitiessuch as manufacturing and marketing of pharmaceuticalformulations trading in Chemicals Textiles etc. Thegroup turnover in the year 1992-93 was Rs. 1616.85 lacs andover Rs. 2000 Lacs (provisional) for the year 1993-94.Now the Company has taken over the existing business of agroup partnership firm i.e. M/s Jenburkt Pharmaceuticalsa going concern which was engaged in the manufacturing andmarketing of pharmaceuticals formulation on Loan Licencebasis under various brand name registered with appropriateauthorities in the name of firm. Brief history of the said partnership firm is as under: M/S Jenburkt Pharmaceuticals was established in the year1984-85 by Mr. Harshad Bhuta along with his brothers.Initially the firm started manufacturing and marketing ofpharmaceuticals formulations under loan and licence basis.Mainly the products under different therapeutic groupnamely nutritional supplement cough syrup-expectorantHaematinic syrup. Initially the firm had launched theirproducts only in Bombay and some parts of MaharashtraGujarat and Madhya Pradesh. Over last Ten years the firmhad successfully launched more than 15 products and it hasexpanded its marketing 10 times to include areas likemetropolitan Delhi Key areas of Uttar Pradesh RajasthanHaryana Karnataka Goa Andhra Pradesh and Kerala. Its field force had consistently grown from 25 to 170people.Jenburkt Products were made available through a wide spreadnetwork of stockists and super stockists through whom theproducts were distributed to thousands of retail chemistoutlets. The firm had a consistent track record of growthand its turnover had increased to Rs. 484 Lacs during 1993-94 from Rs. 39.92 Lacs in the year 1985-86.MAIN OBJECTS OF THE COMPANYTHE MAIN OBJECTS OF THE COMPANY AS PER MEMORANDUM OFASSOCIATION ARE:- 1. To carry on all or any of the business of manufacturersimporters exporters buyers sellers and distributingagents of and dealers in all kinds of patentpharmaceuticals medicinal and medicated preparationspatent medicines drugs herbs and in pharmaceuticalmedicinal proprietary and industrial preparationscompounds and articles of all kinds and chemicalmanufacturers.SUBSIDIARY COMPANYThe company has no subsidiary.

Read More

Jenburkt Pharmaceuticals Management

NamePosition
Ashish U BhutaChairman & Managing Director
Dilip H BhutaWhole Time Director & Chief Financial Officer
View More

Jenburkt Pharmaceuticals FAQs

Jenburkt Pharmaceuticals शेयर का खरीद मूल्य 1177 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Jenburkt Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Jenburkt Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Jenburkt Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Jenburkt Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.49 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Jenburkt Pharmaceuticals का मार्केट कैप 514.57 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Jenburkt Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1410.00 और 944.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost